Skip to main content
. 2022 Apr 28;7:30. doi: 10.1038/s41525-022-00300-5

Fig. 2. Distribution of nucleosome scores and genome-wide z-scores, according to histology.

Fig. 2

Nucleosome scores (a) and genome-wide z-scores (b) are shown for 130 patients with benign ovarian disease, 141 patients with borderline and invasive carcinoma (including 8 patients with metastases) combined, 41 patients with borderline ovarian tumors (BOT), 100 patients with invasive ovarian carcinoma (including 8 patients with metastases), 62 patients with HGSOC, 30 patients with non-HGSOC, and 8 patients with adnexal metastases of other primary cancers. Every case is indicated by a blue dot and HGSOC cases are highlighted in red. The axis of the genome-wide z-scores was truncated for visualization purposes. ***p-value < 0.001; *p-value < 0.05 (Mann–Whitney). Further descriptive statistics are detailed in Supplementary Tables 2 and 3.